✦ LIBER ✦

Carboplatin (CBDCA), ifosfamide (IFX) and etoposide (VP) in advanced non small cell lung cancer (NSCLC): A phase II trial

✍ Scribed by Candamio, S.; Menéndez, M.D.; Irigoyen, A.; Barón, F.J.; Vázquez, F.; Cueva, J.F.; Huidobro, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin (CBDCA) plus etoposide (VP-1

✍ Bernardo, G.; Bernardo, A.; Plastina, M.; Strada, M.R.; Brunetti, G.; Pozzi, U.; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 157 KB

A phase-II trial of carboplatin (CBDCA)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Vinorelbine (VNB) + ifosfamide (IFX) in

✍ Rivero, O.; Lozano, M.; Polera, J.; Matiewjuk, M.; Bonicatto, S.; Callejas, C.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 161 KB

A phase I trial of cisplatin (CDDP), doc

✍ Kunitoh, H; Sawada, M; Watanabe, H; Akiyama, Y; Kusaba, H; Yamamoto, N; Sekine, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Phase II study of ifosfamide (IFX), cisp

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Phase II trial of double platinum with c

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB